MVI, Sanaria explore new approaches to malaria vaccine

11/4/2009 | Thaindian News

The PATH Malaria Vaccine Initiative has teamed up with Sanaria to develop an experimental malaria vaccine that will use a weakened form of the Plasmodium falciparum parasite. The vaccine currently is in human trials in the U.S. Other vaccine approaches being considered by the researchers include preventing the transmission of the disease from mosquitoes to humans.

View Full Article in:

Thaindian News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA